Rheumatic diseases associated with childbearing problems
A new paper in Rheumatology finds that rheumatic diseases can lead to reproductive problems, though some conditions have more detrimental effects than others.
Mar 20, 2024
0
0
A new paper in Rheumatology finds that rheumatic diseases can lead to reproductive problems, though some conditions have more detrimental effects than others.
Mar 20, 2024
0
0
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Oct 10, 2023
0
58
For patients with alopecia areata (AA), corticosteroids are the most commonly used treatment, and by one year, 71.8 percent are receiving no treatment, according to a study published online Sept. 20 in JAMA Dermatology.
Sep 20, 2023
0
1
A new type of medication, JAK inhibitors, can effectively treat moderate to severe alopecia areata, a hair loss condition that has been historically hard to treat.
Aug 17, 2023
0
9
Janus kinase (JAK) inhibitors are associated with more hair regrowth than placebo for patients with alopecia areata, according to a review published online June 27 in JAMA Network Open.
Jul 19, 2023
0
17
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Alopecia areata (AA) is associated with a higher risk for inflammatory arthritis, according to a study published online April 28 in the Journal of the American Academy of Dermatology.
May 15, 2023
0
2
Individuals with psoriasis have double the odds of having celiac disease (CD) versus individuals without psoriasis, according to a research letter published online Feb. 9 in the Journal of the American Academy of Dermatology.
Feb 28, 2023
0
14
(HealthDay)—For patients with alopecia areata (AA), treatment with an inhibitor of janus kinase (JAK)3 and the tyrosine kinase expressed in the hepatocellular carcinoma kinase family, ritlecitinib, and an inhibitor of tyrosine ...
Dec 8, 2021
0
2
(HealthDay)—Androgenetic alopecia is associated with moderate impairment of health-related quality of life (HRQOL) and emotions, according to a review published online July 7 in JAMA Dermatology.
Jul 12, 2021
0
2